Evaluating cancer treatments for people living with HIV
AIDS Malignancy Consortium (AMC) - International Protocol Development Support
This study is looking at better ways to treat and prevent cancer for people living with HIV, and it offers a chance for patients to join clinical trials that could help improve their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11191802 on NIH RePORTER |
What this research studies
This research focuses on the AIDS Malignancy Consortium, which aims to assess and improve cancer treatment and prevention strategies for individuals living with HIV. The consortium operates across multiple international sites in sub-Saharan Africa and Latin America, conducting clinical trials to evaluate various interventions. By gathering expert scientific reviewers, the project will ensure rigorous peer review of clinical trials, enhancing the quality and effectiveness of the treatments being tested. Patients may have the opportunity to participate in these trials, contributing to advancements in care.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals living with HIV who may also be at risk for or diagnosed with cancer.
Not a fit: Patients who do not have HIV or are not at risk for cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options for patients living with HIV.
How similar studies have performed: Previous research has shown success in evaluating cancer treatments for HIV-positive populations, indicating a promising approach.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.